Neutron capture therapy system and target for particle beam generating device
US-2019358470-A1 · Nov 28, 2019 · US
US11517633B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11517633-B2 |
| Application number | US-202117555839-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 20, 2021 |
| Priority date | Dec 21, 2020 |
| Publication date | Dec 6, 2022 |
| Grant date | Dec 6, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described are methods for preparing radionuclides, such as radionuclides having a high specific activity. The disclosed methods include irradiating target nuclide materials, in solution, with a neutron source. The radionuclides can be separated from the target nuclide material by providing a solid carbon nanostructured material, as a suspension of solids, proximal to the target nuclide material in solution and using the recoil to drive adsorption of the radionuclide onto the solid carbon nanostructured material to transfer the radionuclides from the liquid phase (in solution) to the solid phase (adsorbed to the suspended solid carbon nanostructured material). One or more surfactants can be incorporated into the solution to facilitate formation of a stable suspension of the solid carbon nanostructured material.
Opening claim text (preview).
What is claimed is: 1. A method comprising: obtaining a target aqueous suspension comprising: water, a target nuclide material dissolved in the water, a surfactant, and a solid carbon nanostructured material suspended in the water, wherein the solid carbon nanostructured material comprises carbon nanotubes, single walled carbon nanotubes, multiwalled carbon nanotubes, one or more fullerenes, or any combination of these irradiating the target aqueous suspension with a neutron source, wherein at least some of the target nuclide material absorbs neutrons from the neutron source to generate radionuclides that recoil and are adsorbed by the solid carbon nanostructured material to form loaded solid carbon nanostructured material. 2. The method of claim 1 , wherein the surfactant is dissolved in the water, or wherein the target nuclide material comprises a salt dissolved in the water, the salt comprising a target nuclide atom. 3. The method of claim 1 , wherein the target nuclide material comprises a salt including a target nuclide atom having an atomic number from 21 to 83. 4. The method of claim 1 , wherein the target nuclide material comprises a Yb-176 salt, a Re-185 salt, a perrhenate salt of Re-185, a Gd-160 salt, a Mo-98 salt, a Ho-165 salt, a Dy-164 salt, a Ir-191 salt, a Sn-116 salt, a Y-89 salt, a Pd-102 salt, or a Cr-50 salt. 5. The method of claim 1 , wherein the radionuclides comprise Yb-177, Lu-177, Re-186, Gd-161, Tb-161, Mo-99, Tc-99m, Ho-166, Dy-165, Dy-166, Ir-192, Sn-117m, Y-90, Pd-103 or Cr-51. 6. The method of claim 1 , wherein the radionuclides undergo β-particle emission to generate product radionuclides, wherein the product radionuclides comprise Lu-177, Tb-161, Tc-99m, Mo-99, Ho-166, Ir-192, Sn-117m, Y-90, Pd-103, or Cr-51. 7. The method of claim 1 , wherein the solid carbon nanostructured material further comprises layered graphitic sheets, or graphene. 8. The method of claim 1 , wherein the surfactant comprises one or more surfactants selected from the group consisting of gum arabic, bovine serum albumin, gelatin, chitosan, polysaccharides, collagen proteins, and graphene oxide. 9. The method of claim 1 , including preparing the target aqueous suspension by: dissolving the target nuclide material and the surfactant in the water; and mixing the solid carbon nanostructured material with the water, the target nuclide material, and the surfactant to form the target aqueous suspension. 10. The method of claim 1 , wherein about 49.5% or more of the radionuclides generated during the irradiating are captured in the loaded solid carbon nanostructured material. 11. The method of claim 1 , wherein a concentration of the target nuclide material in the target aqueous suspension is from 0.001 mg/ml to 1 mg/ml. 12. The method of claim 1 , wherein a concentration of the solid carbon nanostructured material in the target aqueous suspension is from 0.001 mg/ml to 10 mg/ml. 13. The method of claim 1 , wherein a concentration of the surfactant in the target aqueous suspension is from 0.001 mg/ml to 300 mg/ml. 14. The method of claim 1 , wherein a concentration of the target nuclide material in the target aqueous suspension is from 0.1 mg/ml to 1 mg/ml, wherein a concentration of the solid carbon nanostructured material in the target aqueous suspension is from 0.5 mg/ml to 10 mg/ml, or wherein a concentration of the surfactant in the target aqueous suspension is from 0.1 mg/ml to 100 mg/ml. 15. The method of claim 1 , wherein a mass ratio of the solid carbon nanostructured material to the target nuclide material in the target aqueous suspension is from 10:1 to 100:1. 16. The method of claim 1 , further comprising: separating the loaded solid carbon nanostructured material; and treating the loaded solid carbon nanostructured material with adsorbed radionuclides with an acid to release the radionuclides to solution. 17. The method of claim 16 , wherein the radionuclides released to solution comprise Yb-177, Lu-177, Re-186, Gd-161, Tb-161, Mo-99, Tc-99m, Mo-99, Ho-166, Ir-192, Sn-117m, Y-90, Pd-103, or Cr-51. 18. The method of claim 16 , further comprising separating the solid carbon nanostructured material from the solution. 19. The method of claim 16 , wherein the solution has a specific activity from 50 GBq/mg to 9000 GBq/mg. 20. The method of claim 16 , wherein a ratio of the radionuclides to stable or longer-lived nuclides of the target nuclide material in the solution is from 0.1 to 800.
Graphene oxide · CPC title
Molybdenum · CPC title
by neutron irradiation · CPC title
Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols · CPC title
host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.